Signpath Pharma Competitors and Similar CompaniesClear all
Signpath Pharma's competitors and similar companies include Nektar Therapeutics, Omeros and CureVac.
 Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia. |  Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. | |||
Founding Date | Founding Date 2006 | Founding Date 1990 | Founding Date 1994 | Founding Date 2000 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Sandy, US HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Seattle, US HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US |
Employees | Employees 11 | Employees 61821% increase | Employees 1968% decrease | Employees 82517% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.8 m | Valuation ($) 248.6 m | Valuation ($) 648.3 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €535.2m (FY, 2024) |
Net income | Net income N/A | Net income ($164.1m) (FY, 2025) | Net income ($3.4m) (FY, 2025) | Net income €162.2m (FY, 2024) |
Operating ⚠ | ||||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 3 (FY, 2021) | Phase I Trials Products 3 (May, 2020) |
Funding | ||||
Total funding raised | Total funding raised $ 5.3m | Total funding raised $ 45m | Total funding raised $ 354.8m | Total funding raised $ 1.1b |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyOmeros
HQ
Seattle, US
Employees
196↓ 8% decrease
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
View company
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company